Transient Ischemic Attack

Clinical Trial Finder

Many patients who experience transient ischemic attacks (TIAs) are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

China Registry of Non-disabling Ischemic Cerebrovascular Events

Conditions:   Transient Ischemic Attack;   Minor Stroke
Intervention:   Other: observational only- no intervention
Sponsors:   The First Affiliated Hospital of Zhengzhou University;   National Health and Family Planning Commission, P.R.China;   Beijing Tiantan Hospital
Not yet recruiting - verified March 2017

NATional TUnisian REgistry of Atrial Fibrillation

Condition:   Atrial Fibrillation
Sponsors:   Dacima Consulting;   Société Tunisienne de Cardiologie & de Chirurgie Cardio-Vasculaire
Recruiting - verified March 2017

The Stroke and Exercise Program

Conditions:   Stroke;   Exercise;   Sedentary Lifestyle;   Ischemic Attack, Transient
Interventions:   Behavioral: mHealth-Enhance Physical Activity Intervention;   Other: Physical Activity Intervention
Sponsor:   The Miriam Hospital
Recruiting - verified September 2016

The Peregrine Post-Market Study for the Treatment of Hypertension

Condition:   Hypertension
Intervention:   Device: Peregrine System Infusion Catheter
Sponsor:   Ablative Solutions, Inc.
Recruiting - verified March 2017

Special Drug Use Investigation of Xarelto for Venous Thromboembolism (VTE)

Condition:   Venous Thromboembolism
Intervention:   Drug: Rivaroxaban (Xarelto, BAY59-7939)
Sponsors:   Bayer;   Janssen Research & Development, LLC
Recruiting - verified March 2017

Platelet Reactivity in Acute Non-disabling Cerebrovascular Events

Conditions:   Stroke;   Ischemic Attack, Transient
Interventions:   Drug: Ticagrelor and Acetylsalicylic acid;   Drug: Clopidogrel and Acetylsalicylic acid
Sponsors:   Ministry of Science and Technology of the People´s Republic of China;   Beijing Municipal Science & Technology Commission
Recruiting - verified March 2017

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Standard of care drugs
Sponsors:   Bayer;   Janssen Scientific Affairs, LLC
Recruiting - verified March 2017

Prospective Evaluation of Carotid Free-floating Thrombus

Conditions:   Stroke;   Transient Ischemic Attack
Intervention:   Radiation: Computed Tomographic Angiogram
Sponsors:   Ottawa Hospital Research Institute;   The Ottawa Hospital
Recruiting - verified March 2017

Discharge Educational Strategies for Reduction of Vascular Events

Conditions:   Intracerebral Infarcts;   Ischemic Stroke;   Hemorrhagic Strokes;   TIA's
Intervention:   Behavioral: DESERVE education
Sponsors:   New York University School of Medicine;   Columbia University;   National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified March 2017

Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease

Condition:   Prevention &Amp; Control
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Aspirin;   Drug: Aspirin placebo;   Drug: Rivaroxaban placebo;   Drug: Pantoprazole
Sponsors:   Bayer;   Hamilton Health Sciences Corporation, Population Health Research Institute;   Janssen Research & Development, LLC
Recruiting - verified March 2017

GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)

Conditions:   Stroke;   Atrial Fibrillation
Sponsor:   Boehringer Ingelheim
Recruiting - verified March 2017

GLORIA-AF Registry Program - Second and Third Phases

Conditions:   Stroke;   Atrial Fibrillation
Sponsor:   Boehringer Ingelheim
Recruiting - verified March 2017

Diuretics In the Management of Essential Hypertension (DIME) Study

Condition:   Hypertension
Interventions:   Drug: Thiazide diuretics;   Drug: No diuretics
Sponsors:   Kyoto University;   University of the Ryukyus
Completed - verified March 2017